Erratum: Excessive daytime sleepiness and napping in cognitively normal adults: Associations with subsequent amyloid deposition measured by PiB PET (Sleep DOI: 10.1093/sleep/zsy152);Excessive daytime sleepiness and napping in cognitively normal adults: Associations with subsequent amyloid deposition measured by PiB PET

Sleep

Volumn 41, Issue 10, 2018, Pages

  Spira, Adam P ^a,b,c   An, Yang ^d   Wu, Mark N ^b   Owusu, Jocelynn T ^a   Simonsick, Eleanor M ^d   Bilgel, Murat ^d   Ferrucci, Luigi ^d   Wong, Dean F ^b,e   Resnick, Susan M ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e The Johns Hopkins University   (United States)

Author keywords

aging; biomarkers; brain imaging; epidemiology; napping; neurological disorders; sleepiness

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B; BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; COGNITION; DAYTIME SOMNOLENCE; FEMALE; FOLLOW UP; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SELF REPORT; SLEEP; VOLUME OF DISTRIBUTION RATIO; AGING; BRAIN; BRAIN CHEMISTRY; LONGITUDINAL STUDY; MARYLAND; METABOLISM; ODDS RATIO; PHYSIOLOGY; PROCEDURES; SLEEP DISORDERED BREATHING; SOMNOLENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BALTIMORE; BIOMARKERS; BODY MASS INDEX; BRAIN; BRAIN CHEMISTRY; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; POSITRON-EMISSION TOMOGRAPHY; SLEEP; SLEEP APNEA SYNDROMES; SLEEPINESS;

EID: 85054893673     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/zsy184     Document Type: Erratum

References (53)

1. Scullin MK, et al. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci. 2015;10(1):97-137.
2. Spira AP, et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013;70(12):1537-1543.
3. Ju YE, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587-593.
4. Shokri-Kojori E, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci USA. 2018;115(17):4483-4488.
5. Olsson M, et al. Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer disease. Sleep. 2018;41(5). doi:10.1093/sleep/zsy025
6. Spira AP, Objectively measured sleep and β-amyloid burden in older adults: a pilot study. SAGE Open Medicine. 2014;2:2050312114546520.
7. Osorio RS, et al. Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging. 2014;35(6):1318-1324.
8. Pack AI, et al. Risk factors for excessive sleepiness in older adults. Ann Neurol. 2006;59(6):893-904.
9. Ohayon MM. Determining the level of sleepiness in the American population and its correlates. J Psychiatr Res. 2012;46(4):422-427.
10. Longstreth WT Jr, et al. The epidemiology of narcolepsy. Sleep. 2007;30(1):13-26.
11. Jaussent I, et al. Incidence, worsening and risk factors of daytime sleepiness in a population-based 5-year longitudinal study. Sci Rep. 2017;7(1):1372.
12. Roth T, et al. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther. 1996;18(4):562-576; discussion 561.
13. Foley D, et al. Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. J Am Geriatr Soc. 2001;49(12):1628-1632.
14. Merlino G, et al. Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study. Sleep Med. 2010;11(4):372-377.
15. Ohayon MM, et al. Daytime sleepiness and cognitive impairment in the elderly population. Arch Intern Med. 2002;162(2):201-208.
16. Jaussent I, et al. Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep. 2012;35(9):1201-1207.
17. Hays R, et al. Sleep measures. In: Stewart A, Ware J, eds. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992: 235-259.
18. Sprecher KE, et al. Amyloid burden is associated with selfreported sleep in nondemented late middle-aged adults. Neurobiol Aging. 2015;36(9):2568-2576.
19. Sprecher KE, et al. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults. Neurology. 2017;89(5):445-453.
20. Johns M. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
21. Carvalho DZ, et al. Association of excessive daytime sleepiness with longitudinal β-Amyloid accumulation in elderly persons without dementia. JAMA Neurol. 2018;75(6):672-680.
22. Tamaki M, et al. Effects of a daytime nap in the aged. Psychiatry Clin Neurosci. 1999;53(2):273-275.
23. Campbell SS, et al. Effects of a nap on nighttime sleep and waking function in older subjects. J Am Geriatr Soc. 2005;53(1):48-53.
24. Blackwell T, et al.; Study of Osteoporotic Fractures Group. Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2006;61(4):405-410.
25. Keage HA, et al. What sleep characteristics predict cognitive decline in the elderly? Sleep Med. 2012;13(7):886-892.
26. Cross N, et al. Napping in older people 'at risk' of dementia: relationships with depression, cognition, medical burden and sleep quality. J Sleep Res. 2015;24(5):494-502
27. Li J, et al. Afternoon napping and cognition in Chinese older adults: findings from the china health and retirement longitudinal study baseline assessment. J Am Geriatr Soc. 2017;65(2):373-380.
28. Shock N, et al. Normal Human Aging: The Baltimore Longitudinal Study of Aging. Washington, DC: NIH; 1984.
29. Jenkinson M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825-841.
30. Avants BB, et al. The optimal template effect in hippocampus studies of diseased populations. Neuroimage. 2010;49(3):2457-2466.
31. Jog A, et al. Magnetic resonance image synthesis through patch regression. Proc IEEE Int Symp Biomed Imaging. 2013;2013:350-353.
32. Desikan RS, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968-980.
33. Avants BB, et al. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal. 2008;12(1):26-41.
34. Zhou Y, et al. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage. 2007;36(2):298-312.
35. Bilgel M, et al. Individual estimates of age at detectable amyloid onset for risk factor assessment. Alzheimers Dement. 2016;12(4):373-379.
36. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414.
37. Blessed G, et al. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797-811.
38. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. 3rd ed. Washington, DC: American Psychiatric Association; 1987.
40. Hixson JE, et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
41. Koch W, et al. TaqMan systems for genotyping of diseaserelated polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med. 2002;40(11):1123-1131.
42. Kadotani H, et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA. 2001;285(22):2888-2890.
43. Kang JE, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005-1007.
44. Tabuchi M, et al. Sleep interacts with aβ to modulate intrinsic neuronal excitability. Curr Biol. 2015;25(6):702-712.
45. Shiota S, et al. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice. J Alzheimers Dis. 2013;37(2):325-333.
46. Sun X, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA. 2006;103(49):18727-18732.
47. Li L, et al. Hypoxia increases Abeta generation by altering beta-and gamma-cleavage of APP. Neurobiol Aging. 2009;30(7):1091-1098.
48. Roh JH, et al. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med. 2012;4(150):150ra122.
49. Emamian F, et al. The association between obstructive sleep apnea and Alzheimer's disease: a meta-analysis perspective. Front Aging Neurosci. 2016;8:78.
50. Ju YE, et al. Sleep and Alzheimer disease pathology-A bidirectional relationship. Nat Rev Neurol. 2014;10(2):115-119.
51. Tranah GJ, et al.; SOF Research Group. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol. 2011;70(5):722-732.
52. Musiek ES, et al. Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurol. 2018;75(5):582-590.
53. Kress GJ, et al. Regulation of amyloid-β dynamics and pathology by the circadian clock. J Exp Med. 2018;215(4):1059-1068.